Shield Therapeutics PLC (LSE:STX) - Share price - Overview


Stock Report

Shield Therapeutics PLC STX

Last Price
GBX62.00

Day Change
-1.00|-1.59%

As of 20/03/2019
14:12:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close63.00p
Day Range62.00 - 63.00
Mkt Cap73.35Mil
52-Wk Range14.00 - 73.00
Yield %-
ISINGB00BYV81293
Volume10,158
P/E-3.65
P/S1.09
P/CF-0.04

Share Price

Total Returns 19/03/2019

 Chg (%)  
More ...
Shield Therapeutics PLC24.75 
FTSE 100 TR GBP2.75
 
Financials
201520162017
More ...
Income Statement
Turnover0.000.300.64
Operating Profit-6.43-12.46-20.95
Net Profit-24.49-15.02-19.59
Reported EPS-22.00-15.00-17.00
Balance Sheet
Current Assets2.3323.3815.00
Non Current Assets0.5329.0029.97
Total Assets2.8652.3844.97
Current Liabilities3.583.993.76
Total Liabilities---
Total Equity-18.6448.4041.21
Cash Flow
Operating Cash Flow-4.18-10.26-18.14
Net Change in Cash0.2520.25-7.68
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/09/2018PurchaseMr. Carl Andrew Sterritt34.0088,23530,000.00

Company Profile

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 21/03/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-50.84
Op Mrgn-32.89
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Carl Andrew Sterritt
Non-Executive Director, ChairmanJames Michael Karis
Non-Executive DirectorMr. Peter Hermann William Llewellyn-Davies
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.